Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted ...
Study met the primary endpoint, with a significantly higher proportion of clinical responders on rusfertide compared to placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback